Nyxoah (NYXH) Cash from Investing Activities (2021 - 2026)
Nyxoah's (NYXH) quarterly Cash from Investing Activities came in at $5.4 million in Q1 2026, down 36.97% year-on-year from $8.6 million in Q1 2025, and up 163.64% quarter-over-quarter from -$8.5 million in Q4 2025.
Nyxoah (NYXH) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Nyxoah's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 36.97% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was $28.4 million, a 226.24% increase from a year earlier, with the FY2025 full-year figure at $33.0 million, up 289.05% from the prior year.
- Cash from Investing Activities rose to $5.4 million in Q1 2026 per NYXH's latest filing, from -$8.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $53.4 million in Q1 2022 and bottomed at -$106.2 million in Q2 2022.
- The 5-year median for Cash from Investing Activities is $8.0 million (2023), against an average of -$2.2 million.
- Biggest YoY gain for Cash from Investing Activities was 2593.7% in 2022; the steepest drop was 1501.09% in 2022.
- Year by year, Cash from Investing Activities stood at -$59.5 million in 2022, then soared by 137.56% to $22.3 million in 2023, then tumbled by 131.46% to -$7.0 million in 2024, then dropped by 20.49% to -$8.5 million in 2025, then soared by 163.64% to $5.4 million in 2026.
- Per Business Quant, the three latest NYXH Cash from Investing Activities figures stand at $5.4 million (Q1 2026), -$8.5 million (Q4 2025), and $10.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | 5.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.39 Mn |
| Mar 31, 2026 | 5.39 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Dec 31, 2025 | -8.47 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Sep 30, 2025 | 10.31 Mn |
| Jun 30, 2025 | 21.12 Mn |
| Jun 30, 2025 | 21.12 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Mar 31, 2025 | 8.55 Mn |
| Dec 31, 2024 | -7.03 Mn |
| Dec 31, 2024 | -7.03 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | -30.37 Mn |
| Jun 30, 2024 | -30.37 Mn |
| Mar 31, 2024 | 13.73 Mn |
| Mar 31, 2024 | 13.73 Mn |
| Dec 31, 2023 | 22.34 Mn |
| Dec 31, 2023 | 22.34 Mn |